Table 1 Investigations of case 1 and case 2
Investigation | Results of case 1 | Results of case 2 |
|---|---|---|
Haemoglobin | 13.4 g/dL [12–15] | 12.8 g/dL [12–15] |
White cell count (WBC) | 11.5 × 103 [4–11 × 103] | 6.06 × 103 [4–11 × 103] |
Neutrophils | 88% | 91% |
Lymphocytes | 10% | 7% |
Platelets | 105 × 103 [150–450 × 103]. | 79 × 103 [150–450 × 103] |
C-Reactive Protein (CRP) | 108 mg/dL [0–5] | CRP 311 mg/L [0–5], |
Erythrocyte sedimentation rate [ESR] | 38 mm/1st hour [< 20] | 58 mm/1st hour [< 20] |
Aspartate transaminase [AST] | 200 U/L [< 35] | 79 U/L [< 35] |
Alanine transaminase [ALT | 133 U/L [< 35] | 76 U/L [< 35] |
Lactate dehydrogenase [LDH] | 573 U/L [< 250] | 260 U/L [< 250] |
Troponin I | 0.051 [< 0.012] | 0.03 [< 0.012] |
Ferritin | 498.2 ng/mL [9.3–159] | 287 ng/mL [9.3–153] |
D dimer | 7.76 mg/L [< 0.5] | 5260 mg/mL [< 0.5] |
Procalcitonin | 0.2 ng/mL [< 0.5] | 2.5 ng/mL [< 0.5] |
Blood culture | No growth | No growth |
Sputum culture | No growth | No growth |
COVID 19 IgM antibody titre | 2.8 [< 0.9 to > 1.1], | 3.7 [< 0.9 to > 1.1] |
COVID-19 IgG antibody titre | 28.9 [< 0.9 to > 1.1] | 23 [< 0.9 to > 1.1] |
ECG | Sinus tachycardia | Sinus tachycardia |
2D Echocardiogram | Structurally normal heart with prominent and mildly dilated coronary arteries with no ectatic segments or aneurysms | Structurally normal heart with prominent and mildly dilated coronary arteries but no ectatic segments or aneurysms |
HRCT | Not performed | Extensive consolidation with ground-glass opacities in dependant areas of bilateral lungs |
CMV IgM antibodies | Negative | Not done |
IMN IgM antibodies | Negative | Â |
ANA | 1: 8 | Not done |